LT
Ladenburg Thalmann Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
51
UroGen Pharma
URGN
$873M
|
MK
Matthew Kaplan
| $18.88 | $53.50 |
183%
upside
| Buy |
14 Jun ‘24
1 year ago |
|
52
Red Cat Holdings
RCAT
$850M
|
GM
Glenn Mattson
| $8.52 | $4 |
53%
downside
| Buy |
14 Jun ‘24
1 year ago |
|
53
Entergy
ETR
$39.2B
|
PF
Paul Fremont
| $87.75 | $54.75 |
38%
downside
| Neutral |
12 Jun ‘24
1 year ago |
|
54
Peraso
PRSO
$8.59M
|
JH
Jon Hickman
| $1.38 | $3.75 |
172%
upside
| Buy |
12 Jun ‘24
1 year ago |
|
55
Pinnacle West Capital
PNW
$10.6B
|
PF
Paul Fremont
| $89 | $83.50 |
6%
downside
| Buy |
6 Jun ‘24
1 year ago |
|
56
Sempra
SRE
$52.9B
|
PF
Paul Fremont
| $81.11 | $79 |
3%
downside
| Buy |
29 May ‘24
1 year ago |
|
57
Energous
WATT
$9.88M
|
JH
Jon Hickman
| $6.79 | $60 |
784%
upside
| Buy |
16 May ‘24
1 year ago |
|
58
Capricor Therapeutics
CAPR
$308M
|
AH
Aydin Huseynov
| $6.74 | $25 |
271%
upside
| Buy |
14 May ‘24
1 year ago |
|
59
TG Therapeutics
TGTX
$5.11B
|
MK
Matthew Kaplan
| $32.21 | $40 |
24%
upside
| Buy |
2 May ‘24
1 year ago |
|
|
RNTX
60
Rein Therapeutics, Inc. Common Stock
RNTX
$31M
|
AH
Aydin Huseynov
| $1.33 | $19 |
1,329%
upside
| Buy |
18 Apr ‘24
1 year ago |
|
61
Byrna Technologies
BYRN
$445M
|
JH
Jon Hickman
| $19.62 | $16.25 |
17%
downside
| Buy |
9 Apr ‘24
1 year ago |
|
62
Forte Biosciences
FBRX
$140M
|
MH
Michael Higgins
| $11.26 | $68.75 |
511%
upside
| Buy |
8 Apr ‘24
1 year ago |
|
63
Inuvo
INUV
$49M
|
JH
Jon Hickman
| $3.36 | $10 |
198%
upside
| Buy |
2 Apr ‘24
1 year ago |
|
|
EVAX
64
Evaxion A/S American Depositary Share
EVAX
$18.4M
|
AD
Ahu Demir
| $2.92 | $80 |
2,640%
upside
| Buy |
2 Apr ‘24
1 year ago |
|
65
Monroe Capital Corp
MRCC
$164M
|
MS
Mickey Schlelen
| $7.56 | $9 |
19%
upside
| Buy |
13 Mar ‘24
1 year ago |
|
|
BDRX
66
Biodexa Pharmaceuticals
BDRX
$3.5M
|
AH
Aydin Huseynov
| $5.65 | $2,000 |
35,298%
upside
| Buy |
8 Feb ‘24
1 year ago |
|
67
OGE Energy
OGE
$8.89B
|
PF
Paul Fremont
| $44.15 | $34 |
23%
downside
| Neutral |
16 Jan ‘24
1 year ago |
|
68
Consolidated Edison
ED
$35.4B
|
PF
Paul Fremont
| $98.05 | $92.50 |
6%
downside
| Neutral |
3 Jan ‘24
1 year ago |
|
69
PMV Pharmaceuticals
PMVP
$77.4M
|
AH
Aydin Huseynov
| $1.46 | $7 |
379%
upside
| Buy |
27 Dec ‘23
1 year ago |
|
70
Liquidia Corp
LQDA
$2.48B
|
MK
Matthew Kaplan
| $28.85 | $30 |
4%
upside
| Buy |
21 Dec ‘23
1 year ago |
|
71
Ondas Holdings
ONDS
$1.55B
|
GM
Glenn Mattson
| $5.63 | $3.50 |
38%
downside
| Buy |
11 Dec ‘23
1 year ago |
|
72
Sonnet BioTherapeutics
SONN
$19.5M
|
AD
Ahu Demir
| $2.85 | $56 |
1,865%
upside
| Buy |
27 Nov ‘23
1 year ago |
|
73
Chesapeake Utilities
CPK
$2.96B
|
PF
Paul Fremont
| $125.58 | $100 |
20%
downside
| Buy |
12 Oct ‘23
1 year ago |
|
74
Zura Bio
ZURA
$143M
|
AH
Aydin Huseynov
| $2.20 | $10 |
355%
upside
| Buy |
10 Oct ‘23
1 year ago |
|
75
NiSource
NI
$19B
|
PF
Paul Fremont
| $40.33 | $25 |
38%
downside
| Buy |
6 Oct ‘23
1 year ago |
|